Skip Navigation


Carcinogenesis Advance Access originally published online on June 19, 2006
Carcinogenesis 2006 27(12):2424-2433; doi:10.1093/carcin/bgl066
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/12/2424    most recent
bgl066v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sartippour, M. R.
Right arrow Articles by Brooks, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sartippour, M. R.
Right arrow Articles by Brooks, M. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The combination of green tea and tamoxifen is effective against breast cancer

Maryam R. Sartippour1,3, Richard Pietras2, Diana C. Marquez-Garban2, Hsiao-Wang Chen2, David Heber3, Susanne M. Henning3, Guilan Sartippour1, Liping Zhang1, Ming Lu1, Olga Weinberg2, Jian Yu Rao4 and Mai N. Brooks1,3,*

1 Department of Surgery, University of California, Los Angeles CA 90095, USA
2 Department of Medicine, Division of Oncology, University of California, Los Angeles CA 90095, USA
3 Center for Human Nutrition, University of California, Los Angeles CA 90095, USA
4 Department of Pathology, University of California, Los Angeles CA 90095, USA

*To whom correspondence should be addressed at: Department of Surgery, Division of Oncology, University of California, Box 951782, Los Angeles, CA 90095-1782, USA. Tel: +1 310 206 2215; Fax: +1 310 825 7575; Email: maibrooks{at}mednet.ucla.edu

Epidemiologic data have suggested that green tea may prevent breast cancer. Studies in our laboratory have provided evidence that green tea extract inhibits breast cancer growth by a direct anti-proliferative effect on the tumor cells, as well as by indirect suppressive effects on the tumor-associated endothelial cells. In this study, we asked whether concurrent administration of green tea may add to the anti-tumor effects of standard breast cancer therapy. We observed that green tea increased the inhibitory effect of tamoxifen on the proliferation of the ER (estrogen receptor)-positive MCF-7, ZR75, T47D human breast cancer cells in vitro. This combination regimen was also more potent than either agent alone at increasing cell apoptosis. In animal experiments, mice treated with both green tea and tamoxifen had the smallest MCF-7 xenograft tumor size, and the highest levels of apoptosis in tumor tissue, as compared with either agent administered alone. Moreover, the suppression of angiogenesis in vivo correlated with larger areas of necrosis and lower tumor blood vessel density in treated xenografts. Green tea decreased levels of ER-{alpha} in tumors both in vitro and in vivo. We also observed that green tea blocked ER-dependent transcription, as well as estradiol-induced phosphorylation and nuclear localization of mitogen-activated protein kinase. To our knowledge, this study is the first to show the interaction of green tea with the ER pathway, as well as provide mechanistic evidence that the combination of green tea and tamoxifen is more potent than either agent alone in suppressing breast cancer growth. These results may lead to future improvements in breast cancer treatment and prevention.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Kumar, L. Titus-Ernstoff, P. A. Newcomb, A. Trentham-Dietz, G. Anic, and K. M. Egan
Tea Consumption and Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 341 - 345.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H.-C. Huang, T.-D. Way, C.-L. Lin, and J.-K. Lin
EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein
Endocrinology, December 1, 2008; 149(12): 5972 - 5983.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. M. Sotoca Covaleda, H. van den Berg, J. Vervoort, P. van der Saag, A. Strom, J.-A. Gustafsson, I. Rietjens, and A. J. Murk
Influence of Cellular ER{alpha}/ER{beta} Ratio on the ER{alpha}-Agonist Induced Proliferation of Human T47D Breast Cancer Cells
Toxicol. Sci., October 1, 2008; 105(2): 303 - 311.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Auger, W. Mullen, Y. Hara, and A. Crozier
Bioavailability of Polyphenon E Flavan-3-ols in Humans with an Ileostomy
J. Nutr., August 1, 2008; 138(8): 1535S - 1542S.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Khan, F. Afaq, and H. Mukhtar
Apoptosis by dietary factors: the suicide solution for delaying cancer growth
Carcinogenesis, February 1, 2007; 28(2): 233 - 239.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.